Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Baricitinib improved hair loss and arthritis in a lupus patient.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Onyx® embolization effectively treats facial arteriovenous malformations with minimal complications.

Dutasteride may help reduce brain inflammation and improve cognition.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Transfected cells with VEGF and FGF2 genes improve skin wound healing by enhancing blood flow and regeneration.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

A special gel with medicine helps prevent melanoma from coming back after surgery.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

A new treatment using hybrid vesicles with gold nanoparticles and finasteride significantly improves hair regrowth for androgenetic alopecia.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Combining laser with PRP is more effective for vitiligo than PRP alone.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.